Medtronic Operating Income 2010-2024 | MDT
Medtronic annual/quarterly operating income history and growth rate from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- Medtronic operating income for the quarter ending January 31, 2024 was $1.483B, a 6.61% increase year-over-year.
- Medtronic operating income for the twelve months ending January 31, 2024 was $5.659B, a 1.23% increase year-over-year.
- Medtronic annual operating income for 2023 was $5.485B, a 4.66% decline from 2022.
- Medtronic annual operating income for 2022 was $5.753B, a 28.3% increase from 2021.
- Medtronic annual operating income for 2021 was $4.484B, a 6.41% decline from 2020.
| Medtronic Annual Operating Income (Millions of US $) |
|
|---|---|
| 2023 | $5,485 |
| 2022 | $5,753 |
| 2021 | $4,484 |
| 2020 | $4,791 |
| 2019 | $6,268 |
| 2018 | $6,640 |
| 2017 | $5,383 |
| 2016 | $5,361 |
| 2015 | $3,766 |
| 2014 | $3,813 |
| 2013 | $4,755 |
| 2012 | $4,748 |
| 2011 | $4,297 |
| 2010 | $4,714 |
| 2009 | $3,833 |
| Medtronic Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2024-01-31 | $1,483 |
| 2023-10-31 | $1,340 |
| 2023-07-31 | $1,269 |
| 2023-04-30 | $1,567 |
| 2023-01-31 | $1,391 |
| 2022-10-31 | $1,403 |
| 2022-07-31 | $1,124 |
| 2022-04-30 | $1,672 |
| 2022-01-31 | $1,659 |
| 2021-10-31 | $1,563 |
| 2021-07-31 | $859 |
| 2021-04-30 | $1,604 |
| 2021-01-31 | $1,277 |
| 2020-10-31 | $930 |
| 2020-07-31 | $673 |
| 2020-04-30 | $316 |
| 2020-01-31 | $1,639 |
| 2019-10-31 | $1,351 |
| 2019-07-31 | $1,485 |
| 2019-04-30 | $1,946 |
| 2019-01-31 | $1,542 |
| 2018-10-31 | $1,544 |
| 2018-07-31 | $1,236 |
| 2018-04-30 | $1,928 |
| 2018-01-31 | $1,436 |
| 2017-10-31 | $1,894 |
| 2017-07-31 | $1,382 |
| 2017-04-30 | $1,684 |
| 2017-01-31 | $1,147 |
| 2016-10-31 | $1,385 |
| 2016-07-31 | $1,167 |
| 2016-04-30 | $1,575 |
| 2016-01-31 | $1,355 |
| 2015-10-31 | $1,300 |
| 2015-07-31 | $1,131 |
| 2015-04-30 | $159 |
| 2015-01-31 | $1,275 |
| 2014-10-31 | $1,193 |
| 2014-07-31 | $1,139 |
| 2014-04-30 | $305 |
| 2014-01-31 | $1,025 |
| 2013-10-31 | $1,206 |
| 2013-07-31 | $1,277 |
| 2013-04-30 | $1,191 |
| 2013-01-31 | $1,218 |
| 2012-10-31 | $1,186 |
| 2012-07-31 | $1,160 |
| 2012-04-30 | $1,215 |
| 2012-01-31 | $1,153 |
| 2011-10-31 | $1,221 |
| 2011-07-31 | $1,159 |
| 2011-04-30 | $982 |
| 2011-01-31 | $1,147 |
| 2010-10-31 | $1,089 |
| 2010-07-31 | $1,079 |
| 2010-04-30 | $1,056 |
| 2010-01-31 | $1,267 |
| 2009-10-31 | $1,224 |
| 2009-07-31 | $1,167 |
| 2009-04-30 | $660 |
| 2009-01-31 | $980 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $112.214B | $31.227B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $179.548B | 23.51 |
| Stryker (SYK) | United States | $125.611B | 30.08 |
| Boston Scientific (BSX) | United States | $110.560B | 35.22 |
| EssilorLuxottica (ESLOY) | France | $102.987B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.408B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.858B | 28.37 |
| ResMed (RMD) | United States | $32.134B | 30.17 |
| Terumo (TRUMY) | Japan | $26.594B | 37.56 |
| Koninklijke Philips (PHG) | Netherlands | $25.426B | 19.70 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.492B | 15.64 |
| Baxter (BAX) | United States | $17.846B | 12.69 |
| Insulet (PODD) | United States | $12.897B | 57.19 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.375B | 0.00 |
| Demant (WILYY) | Denmark | $11.282B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.326B | 27.23 |
| BellRing Brands (BRBR) | United States | $7.474B | 35.15 |
| Lantheus Holdings (LNTH) | United States | $5.744B | 14.31 |
| Haemonetics (HAE) | United States | $4.838B | 23.94 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Perrigo (PRGO) | Ireland | $4.027B | 12.21 |
| Prestige Consumer Healthcare (PBH) | United States | $3.230B | 15.37 |
| Envista Holdings (NVST) | United States | $3.140B | 12.96 |
| Neogen (NEOG) | United States | $2.961B | 28.48 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.851B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.839B | 15.76 |
| Green Thumb Industries (GTBIF) | United States | $2.604B | 51.58 |
| TG Therapeutics (TGTX) | United States | $2.547B | 71.65 |
| ICU Medical (ICUI) | United States | $2.516B | 22.20 |
| Agios Pharmaceuticals (AGIO) | United States | $1.884B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.782B | 52.23 |
| Verano Holdings (VRNOF) | United States | $1.676B | 0.00 |
| Warby Parker (WRBY) | United States | $1.654B | 0.00 |
| InMode (INMD) | Israel | $1.596B | 8.48 |
| Owens & Minor (OMI) | United States | $1.377B | 12.00 |
| AdaptHealth (AHCO) | United States | $1.317B | 9.79 |
| National Vision Holdings (EYE) | United States | $1.221B | 38.85 |
| AtriCure (ATRC) | United States | $1.062B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.005B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.853B | 0.00 |
| Evolus (EOLS) | United States | $0.840B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.738B | 15.72 |
| Cresco Labs (CRLBF) | United States | $0.736B | 0.00 |
| Quanterix (QTRX) | United States | $0.659B | 0.00 |
| Valneva SE (VALN) | France | $0.616B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.614B | 14.43 |
| PetIQ (PETQ) | United States | $0.593B | 19.38 |
| Surmodics (SRDX) | United States | $0.500B | 31.30 |
| Jin Medical (ZJYL) | China | $0.474B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.472B | 0.00 |
| ZimVie (ZIMV) | United States | $0.465B | 39.60 |
| Aurora Cannabis (ACB) | Canada | $0.404B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.365B | 11.74 |
| Cerus (CERS) | United States | $0.361B | 0.00 |
| Biote (BTMD) | United States | $0.350B | 8.06 |
| Zynex (ZYXI) | United States | $0.336B | 45.91 |
| Sanara MedTech (SMTI) | United States | $0.281B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.276B | 27.31 |
| TriSalus Life Sciences (TLSI) | United States | $0.272B | 0.00 |
| MacroGenics (MGNX) | United States | $0.267B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.243B | 15.31 |
| Veru (VERU) | United States | $0.208B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.206B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.201B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.200B | 0.00 |
| Omeros (OMER) | United States | $0.191B | 0.00 |
| High Tide (HITI) | Canada | $0.173B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.169B | 81.00 |
| InterCure (INCR) | Israel | $0.154B | 26.00 |
| Quipt Home Medical (QIPT) | United States | $0.138B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.132B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.128B | 18.14 |
| Cellectar Biosciences (CLRB) | United States | $0.113B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
| MariMed (MRMD) | United States | $0.094B | 0.00 |
| Brainsway (BWAY) | Israel | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.091B | 7.82 |
| Chimerix (CMRX) | United States | $0.088B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.081B | 0.00 |
| Safety Shot (SHOT) | United States | $0.071B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.069B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.060B | 3.91 |
| Apyx Medical (APYX) | United States | $0.055B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.055B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| Bright Green (BGXX) | United States | $0.043B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 15.20 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| ImmuCell (ICCC) | United States | $0.037B | 0.00 |
| Exagen (XGN) | United States | $0.032B | 0.00 |
| Nephros (NEPH) | United States | $0.024B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.014B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.002B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |